{"name":"Bionomics Limited","slug":"bionomics-limited","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi9AFBVV95cUxOVHlOOFA5aW01YXZ4RWt3S3ZJUjNYWkRtMXJzNjNlWjVPcEk2Y1FlNXVrcHRjUzJPeklNSUZQaWpqaUdKUWhNMmZSNnBPMkllSmFYbnhxNzJsRm1IbDg0NjE0TnNhOWRaNzVIWFhDZVBVblNaVkxlUEFVYnU2N3RlSGZHYmRDckYtMXE1ek54RmtsZjh0SG5OZktSdlpKVlMzcHA5S0RCd21ydFVsZG9ESXRwVHUyU0JydDA4XzhKWjBPenBfYUVBMDhLX1hhNUtTX2doeEZaVWo4aHVDM2RDazY3VXVoRWs1UV9rYWpOVHJXcjR0?oc=5","date":"2026-03-30","type":"pipeline","source":"Barchart.com","summary":"Post-Traumatic Stress Disorder Treatment Pipeline Shows Strong Momentum as 20+ Pharma Companies in the Race | DelveInsight - Barchart.com","headline":"Post-Traumatic Stress Disorder Treatment Pipeline Shows Strong Momentum as 20+ Pharma Companies in the Race | DelveInsig","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxPYkMwNWVXdkZFXzJnUkptSTg0djhXS2pINWJVVGlLTGE4LWwwWVgwaXN4dFRCMm9jUnViWV9RaDFhWWtmdU9xVEoxUWFUODQxNWRZWXRlTmRlNjIzS0lyYjQ2bmxpTUJfMS0xMjVtd0RIMzJIWGRLbXh4MXZ3UmtFQWlLUTRwdWtFNk9YQXZyZUJSS3JBSmc?oc=5","date":"2026-03-30","type":"pipeline","source":"openPR.com","summary":"Post-Traumatic Stress Disorder Treatment Pipeline Shows - openPR.com","headline":"Post-Traumatic Stress Disorder Treatment Pipeline Shows","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAJBVV95cUxQZGZhUldiU3piWjBKcmRIOW9HbUtuUGJkdXJ6RmhtaDFEOTZHY2RQaDM2Y2hmSDcyRGZCWkgwSGN0RDIxYm0xTVRjMUVVX2cxTVdsRTQ0X1lGRGhha2k2Q0xHOFdPRFFxSm5zVnc1SnpPRmFDVUtrUFBhcHBTSE5HWlV1Vm5wMnpiY0swVDhsZjRIUzU0WXJjemRiUzJ6bUFnTVk3YXVhdWRsX01PM0d3dkE5aEdrX3NCTmFHeU43TnpIbEpFT09iejdadHY1ZnJ4d1ZpMnJjRXJ1NHh1U0ZmdkFDcHVyVFNXelRiVG9BVkRjOG9Qdzkya2JvMk9sWGFndFdXMlNncXhWSHJDTUFNUGN1OWZFZ1pYazBlVUd1QzJzWDJOWGFZOUhmWlNrVnJjbG9kRE9UOXhWalMz?oc=5","date":"2026-03-11","type":"pipeline","source":"prnewswire.com","summary":"Bipolar Depression Market Expected to Witness Accelerated Expansion During the Forecast Period (2026-2036) Amid Advancements in Psychiatric Therapies | DelveInsight - prnewswire.com","headline":"Bipolar Depression Market Expected to Witness Accelerated Expansion During the Forecast Period (2026-2036) Amid Advancem","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswJBVV95cUxQVEs4c3p6enpMd09lNDY0c0RTZVlPSmtwTGFIM05iSGg4dkN6NmJNSkZXdjZQbWpJT0tXMUh0R2JabHlfRHJONWxEUDg2X3E2UGF4VzdaZDB0VVRMSE52Z1dDRmI0Q1FoMWtnRXlOY3hRaXo0YkxNbFVKN1lXTHlTeDM4WDJlVDQ1ZE5vcFNCX3ZLVFNDWExkNU42eHg5QnlBX2tGMTZiUWRlRWRjelpCVUlyV1IySGtPN3pJbzRSQzdnQmFNZ19maHpTLWhwUEc0Q25GMEVuYzJua2NPSGZHdXNpbEF2T183V3liS0hhTXJIMHotazFnSFluZGNJRVVLLUpKaEE4X2NKLVpJblpybW9QR3dhMmFPeFgtUS1ZLVFpWjgyQjB6QU00M1Y3V0xFZWhJ?oc=5","date":"2025-06-26","type":"trial","source":"prnewswire.com","summary":"Post-Traumatic Stress Disorder Market Set to Expand Significantly During the Study Period (2020-2034) with Pipeline Innovation and Unmet Needs | DelveInsight - prnewswire.com","headline":"Post-Traumatic Stress Disorder Market Set to Expand Significantly During the Study Period (2020-2034) with Pipeline Inno","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMizgJBVV95cUxOdGVFLTlnM2pwZGVyTk1WaWxwSFR2dko3SVlxNnhTUHR5aWVLa3Z1STd6RC1ZbkxlbkJRVGFqVmVVSjVfclNiR3lkZGc1UUhITDNJMHJlRkNUVkJyaHk3cVQtYXZoUU9JZjZ2TXpiLVZJQXg3c19OOFdnUDZrcGRVOHRrNjJaMmtoLWtRYkNuREIyYVhVX1dSZjlNamJIM0RjUUlHRFpiUFN5cTAxU0ZZalRUT3cyMG9Kc3ZuUmlOcXo3OTlXNFZqTnJORVNtTFZFcldmTEtfX0U4eEFYYVBCTDc4amJEY1ZZNTZtcFl6b2dsOHNNUG9Ba1AzUFFUQjZVbW54RHBxdGF4eElyN2RqWjd1bXNFY1pGcnVQdEVWRVR5SnRMcE1KRnFFa1I1bUtvVTZ2ckxBNF8tcHVYVUtJU0taUlJNVW9TWHJwVl93?oc=5","date":"2025-03-04","type":"trial","source":"GlobeNewswire","summary":"Dopamine Receptor Antagonists Clinical Trial Pipeline - GlobeNewswire","headline":"Dopamine Receptor Antagonists Clinical Trial Pipeline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxQZVRtTFFTRUJmNi1jb2pvWTB1eWY1MGphOUJmZ0ZIOU92empkOWtiOG1LXzU3cGViRHRnVTVuM2pGSGdiX3dPaG5meGpxQzhyQkxiTTBMT3BlNDR6VjBPeXF5T2FRZ1Z4MDNxNVptazRsdUdwTzd1cXFqcERWb1dvWUMwS2g4N1VxeVJPLUItZVQ1cVA1YzkzSC10NS1udw?oc=5","date":"2024-10-01","type":"pipeline","source":"SEC.gov","summary":"Press Release, dated October 1, 2024, issued by Bionomics Limited. - SEC.gov - SEC.gov","headline":"Press Release, dated October 1, 2024, issued by Bionomics Limited. - SEC.gov","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxQc1ZrckZpdGJyR2NBUDk0cFB1dThBSl9CYjZ0Tk9hNnlqalRkdl9fZDlKQllkM0tKN3lLYm93SDA2RFVmXzh5WWlycGNRM0dSd3BZSFJ1LTJqQ0hXRHhUVmVRbnJqbmxwcjFoWDhyYnVnYWhRUzBMZ1g1R1ByRUFUdU1mNHVoUzdCX2tPMjZIMDRzVnI1WWNnOHZEZjVjU2lKbVFfRkM5djVVRGd4S0FmdDBwdlpvQmswMTRSb09XODB3ZWc?oc=5","date":"2023-03-06","type":"pipeline","source":"Stockhead","summary":"Check Up: Almost half a billion US dollars raised to bring back mammoth, dodo, and Tassie tiger - Stockhead","headline":"Check Up: Almost half a billion US dollars raised to bring back mammoth, dodo, and Tassie tiger","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1AFBVV95cUxPNzdMOUxZT3haUnBUcEtOSF9qeXA0MUpVODRwXzd0VHlNeW9IRU5oR2ZLY3lMX3RsY3BUZC1QSTVFdlUxb0hMUEs3S2wyWHdfZ3g1SlJMd2ZKRkRDX1BPS1FUeXVJdVVFUnBWQmozQnEzemhvZzNsd0JmSlg2M1RtMnhtZDV1ZFFaNWNFUzB1NDYxTU81U3hLTW9nUkNUZ1pFOXFJRk04bUc2SWREaEthYWx6N1lyNlA3NE9Kd3JaazUxZkstSzZqY2xNZlRDa2VDMHA3YQ?oc=5","date":"2021-09-21","type":"trial","source":"BioPharma APAC","summary":"Bionomics Prepares BNC210 for Start of Phase 2 Acute Treatment of Social Anxiety Disorder Trial - BioPharma APAC","headline":"Bionomics Prepares BNC210 for Start of Phase 2 Acute Treatment of Social Anxiety Disorder Trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwJBVV95cUxORTNYUjBfeDhmTmwxWnl6cHNEYjNRWTNrdVc1bnROS2U2YnY3VW16N1ZRWWR0QnMzemxtRGRTQlp3M0FoalNfcmo2X3hTZUVIcHd3enNOUkVsVXZwSHRURmxwSWNkbWZocWtwUVVuSUE3RWRMbHhnUTRFaUMxYWVhclpWc2tvcVNhSzBGTnpnZDJQOGluVi1DOVZOajJSVkFsaDZiWU1aUHNIcHVWbjZpYWdFUFJHVmsyU3hmWEItYTkwWFFtbUsxNDEtVG9MWE4yYzlLNzV3Rm9OZTdNREx3SVBRZUNFVXFsVjZLbEgwRjVlUF94VnZURjkybWpKc2p4T2hucUltVHM3NlN2UjBtZGl3RkU3UHZBS3I4YmpmNlc1SEhlM19RbmFxd3lZV2dzSUxLZjBiMA?oc=5","date":"2020-11-24","type":"pipeline","source":"businesswire.com","summary":"Post-Traumatic Stress Disorder (PTSD) Therapeutics Market 2020-2024- Featuring AstraZeneca Plc, Bionomics Ltd., Among Others to Contribute to the Market Growth - businesswire.com","headline":"Post-Traumatic Stress Disorder (PTSD) Therapeutics Market 2020-2024- Featuring AstraZeneca Plc, Bionomics Ltd., Among Ot","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9wFBVV95cUxPQWZEMWZiWFljLWJ6Mm5pMXN3UWEwdkFvbFBFVHdxTFExVDBnQ0NoWEdrVWZ2TXlZQUloTnd0c0dKUk91cjh0cjdyU0dPSFFBeG5XZFcwa0loSlZWMUZrWFdfZjFRMGJEaXFtV1BiWGI5Ynd1NFZlV1UyUXpGck53YmhxWk5DY3lUX2JpbHNoRk5mNXo5TzlSZnJ2Y0JlOHkwX0lpSmlDUzVrY1JLbkJvWEV3WThkdzRTTENtSzI0N3Uzcm4xcm14dnVmSmpsc3F5WVR3TWVJV05sZGo0ZHpqMEl1YjlVdm1nbG5YT3ZWMFVxVHExeF9N?oc=5","date":"2017-12-20","type":"pipeline","source":"BioSpectrum Asia","summary":"Women Achiever's Spl: Seizing opportunity however small it may be: DR DEBORAH RATHJEN CEO, Bionomics, Australia - BioSpectrum Asia","headline":"Women Achiever's Spl: Seizing opportunity however small it may be: DR DEBORAH RATHJEN CEO, Bionomics, Australia","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxQQ3dKNThDaXVpQU9zcTc5UkZlVlFYSmQzUzZDQ0hUZFVTOXFjbmR6ZEhLai1QWVByRExDQllpNnRTWDhvYWhKRm5ybWd0cTF0RjZVRHNFQWtKUW10QWROdmNVZkZVcW1oS0N0VC1rblU4STEyVEFZZHgxazNUZEJUSHhaR29PNk80ZHY1Q2Jlaw?oc=5","date":"2017-03-24","type":"trial","source":"Pharmafile","summary":"A patent analytics study of the Australian pharmaceutical industry - Pharmafile","headline":"A patent analytics study of the Australian pharmaceutical industry","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4gFBVV95cUxQT0lxMzVrYTVHaGJaN3ZIYzUwNktEOXNSSU1uSzNPTXh6N3IzdmM4alZnYTVrRDhIX2tuRkhSelVZbFQyTGl6c1RKeU9DYVQ1cXduOHFGWjJqY24zcGpSb0dMVzFiVWp2UFJraW1oeGdvWjFZeThaTDZrd0ctcGhlcDRKS2lSaFlhano0VzVNTXZGN2J0T1NJQ1RxRTM0M05wcDdBMnNYVDFLVnVMcTU3Nm1RbXlWN0VlMFh0QzBMXzhuY2xjMEZoMnVfVjIzVnlVU01HVnRrM0h5SzNsSWFxM3lR?oc=5","date":"2009-10-16","type":"trial","source":"proactiveinvestors.com","summary":"Bionomics clinical trials for anxiety drug BNC210, show superiority to Valium, Prozac - proactiveinvestors.com","headline":"Bionomics clinical trials for anxiety drug BNC210, show superiority to Valium, Prozac","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}